Active Ingredient (In Each Tablet)
Dimenhydrinate 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by Chain Drug Marketing Association, Inc. for the product Motion Sickness Relief (NDC 83324-032). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
for children under 2 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over | ■ take 1 to 2 tablets every 4-6 hours ■ do not take more than 8 tablets in 24 hours, or as directed by a doctor |
| children 6 to under 12 years | ■ give 1/2 to 1 tablet every 6-8 hours ■ do not give more than 3 tablets in 24 hours, or as directed by a doctor |
| children 2 to under 6 years | ■ give 1/2 tablet every 6-8 hours ■ do not give more than 1 1/2 tablets in 24 hours, or as directed by a doctor |
croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
1-800-426-9391
NDC 83324-032-12
QC®
QUALITY
CHOICE
*Compare to the
Active Ingredient in
Dramamine® Original Formula
Motion Sickness Relief
Original Formula
Dimenhydrinate 50 mg | Antiemetic
Prevents and Relieves: Nausea, Vomiting & Dizziness
for Children & Adults
12 Tablets
actual
size
Dye Free
* Please review the disclaimer below.